| 1 |
Which of the following best describes the concept of "beat perception" as it relates to the auditory capabilities of newborn infants?
|
The extraction of a consistent rhythm from a sequence of sounds. |
|
Beat perception refers to the ability to detect and anticipate a regular pulse or rhythm in auditory sequences—something that even newborn infants are capable of, showing an innate sensitivity to temporal patterns in sound.
|
Newborn infants detect the beat in music. Proceedings of the National Academy of Sciences
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
According to the research, what experimental method is used to differentiate beat perception from statistical learning in newborns?
|
Monitoring brain activity using EEG during auditory stimulation. |
|
Researchers use EEG to measure newborns’ brain responses to rhythmic patterns. This allows them to distinguish beat perception from statistical learning.
|
Newborn infants detect the beat in music. Proceedings of the National Academy of Sciences
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does the mismatch response (MMR) in EEG studies indicate about newborns' auditory processing?
|
Sensitivity to regularity violations in sound sequences. |
|
The Mismatch Response (MMR) in EEG studies reflects the newborn brain’s automatic detection of deviations from expected auditory patterns, indicating early sensitivity to rhythmic and structural regularities in sound.
|
Newborn infants detect the beat in music. Proceedings of the National Academy of Sciences
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What does the term "statistical learning" refer to in the context of auditory processing in newborns?
|
Extraction of regularities from the order of sounds without explicit feedback. |
|
Statistical learning in newborns refers to their innate ability to detect patterns—like which sounds commonly follow others—by passively listening, without needing conscious instruction or feedback.
|
Statistical learning by 8-month-old infants. Science
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which condition in the EEG study did NOT result in a differentiation between beat and offbeat responses in newborns?
|
Jittered condition. |
|
In the jittered condition, the timing between sounds is irregular, disrupting the regular beat structure. As a result, newborns’ EEG responses did not show a differentiation between beat and offbeat positions—indicating that beat perception relies on temporal regularity.
|
Newborn infants detect the beat in music. Proceedings of the National Academy of Sciences
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Which neural mechanism is thought to underlie the synchronization of movement to a beat?
|
Neural entrainment. |
|
Neural entrainment is the process by which brain rhythms align with external rhythmic stimuli, such as music beats. This mechanism enables the synchronization of movement to rhythm, even in newborns and across species.
|
Pulse and meter as neural resonance. Annals of the New York Academy of Sciences
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
How does beat perception in newborns relate to their later musical abilities?
|
It is fundamental for developing rhythmic coordination and timing. |
|
Beat perception in newborns lays the foundation for rhythmic coordination and timing, skills essential for later musical abilities such as clapping, dancing, or playing in time with music.
|
Newborn infants detect the beat in music. Proceedings of the National Academy of Sciences
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What is the primary purpose of using EEG in studies of auditory processing in newborns?
|
To record brain responses to sounds. |
|
EEG is used in newborn auditory studies to measure electrical brain activity in response to sound stimuli, helping researchers understand how infants process rhythm, pitch, and auditory patterns.
|
Newborn infants detect the beat in music. Proceedings of the National Academy of Sciences
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What does an isochronous condition in an auditory study typically involve?
|
A consistent temporal interval between sounds. |
|
An isochronous condition involves sounds played at regular, evenly spaced time intervals, which is essential for studying beat perception, as it provides a predictable rhythmic structure.
|
Newborn infants detect the beat in music. Proceedings of the National Academy of Sciences
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
Which auditory feature is NOT directly studied in the newborn auditory processing research?
|
Language comprehension. |
|
The newborn auditory studies focus on basic rhythmic and pattern detection abilities like beat perception and statistical learning, rather than complex language comprehension, which develops later.
|
Newborn infants detect the beat in music. Proceedings of the National Academy of Sciences
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What term is used to describe the appearance of scientific credibility used in the marketing of unproven cell-based therapies?
|
Tokens of scientific legitimacy |
|
“Tokens of scientific legitimacy” refers to using scientific-sounding language, images, or claims to give unproven therapies a false appearance of credibility and trustworthiness in marketing.
|
Marketing unproven stem cell therapies: Tokens of scientific legitimacy and the allure of scientific progress. Stem Cell Reports
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
According to the article, which of the following is NOT a recognized reporting mechanism for adverse effects from cell and gene therapies?
|
Consumer Protection Agencies |
|
Consumer protection agencies are not formal or recognized channels for reporting adverse effects of cell and gene therapies. Instead, official pharmacovigilance systems like ClinicalTrials.gov, MedWatch (FDA), EudraVigilance (EMA), and TGA’s Safety Reporting Portal are used.
|
Reporting adverse effects of cell and gene therapies: Current challenges and recommendations. Regenerative Medicine
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What ethical consideration is primarily challenged by direct-to-consumer marketing of unproven cell and gene therapies?
|
Informed consent processes |
|
Direct-to-consumer marketing of unproven therapies often bypasses full disclosure of risks and evidence, compromising patients’ ability to give truly informed consent before treatment.
|
Ethical challenges in marketing unproven cell and gene therapies. Journal of Medical Ethics
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What key feature differentiates proven CGT products from unproven ones according to regulatory standards?
|
Pre-marketing authorization by regulatory bodies |
|
Proven cell and gene therapy (CGT) products must undergo rigorous regulatory review and obtain pre-market approval, ensuring safety and efficacy before being marketed.
|
Regulatory pathways for cell and gene therapies: Distinguishing proven products from unproven ones. Regenerative Medicine
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
Which of the following is a risk associated with unproven CGT products highlighted in the article?
|
Potential for serious health risks |
|
Unproven cell and gene therapies may cause harmful side effects or complications due to lack of proper testing and regulation, posing serious health risks to patients.
|
Risks of unproven cell and gene therapies: A critical review. Stem Cell Reports
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Which of the following is NOT a typical characteristic of unproven CGT products as discussed in the article?
|
Approval by major regulatory agencies |
|
Unproven CGT products typically lack regulatory approval, unlike legitimate therapies which must be authorized after thorough evaluation.
|
Characteristics of unproven cell and gene therapies: A critical overview. Regenerative Medicine
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
How do regulatory bodies like the FDA and EMA ensure the safety of CGT products?
|
By requiring rigorous pre-marketing clinical trials |
|
Regulatory agencies ensure safety by mandating extensive clinical testing before approving CGT products for market, verifying efficacy and minimizing risks.
|
Regulatory oversight of cell and gene therapies: Ensuring safety and efficacy. Regenerative Medicine
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What is the primary goal of the ISCT's position on cell and gene therapies as mentioned in the article?
|
To support evidence-based products and oppose unproven ones |
|
The ISCT emphasizes promoting scientifically validated, safe, and effective therapies while discouraging unproven, potentially harmful treatments.
|
The ISCT position on unproven cell and gene therapies. Cytotherapy
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What is a potential consequence for patients using unproven CGT products?
|
Risk of serious adverse effects |
|
Unproven CGT products may cause harmful health outcomes due to lack of proper testing and regulation.
|
Risks associated with unproven cell and gene therapies. Stem Cell Reports
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What role does the ISCT play in the context of cell and gene therapies?
|
It opposes the premature commercialization of unproven therapies. |
|
The ISCT advocates for responsible development and commercialization, emphasizing safety and scientific evidence, and opposes marketing unproven therapies.
|
The ISCT’s role in promoting responsible cell and gene therapy practices. Cytotherapy
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|